Background: Endoplasmic reticulum [ER] stress was shown to be pivotal in the pathogenesis of inflammatory bowel disease. Despite progress in inflammatory bowel disease [IBD] drug development, not more than one-third of patients achieve steroid-free remission and mucosal healing with current therapies. Furthermore, patient stratification tools for therapy selection are lacking. We aimed to identify and quantify epithelial ER stress in a patient-specific manner in an attempt towards personalised therapy. Methods: A biopsy-derived intestinal epithelial cell culture system was developed and characterised. ER stress was induced by thapsigargin and quantified with a BiP enzyme-linked immunosorbent assay [ELISA] of cell lysates from 35 patients with known genotypes, who were grouped based on the number of IBD-associated ER stress and autophagy risk alleles. Results: The epithelial character of the cells was confirmed by E-cadherin, ZO-1, and MUC2 staining and CK-18, CK-20, and LGR5 gene expression. Patients with three risk alleles had higher median epithelial BiP-induction [vs untreated] levels compared with patients with one or two risk alleles [p = 0.026 and 0.043, respectively]. When autophagy risk alleles were included and patients were stratified in genetic risk quartiles, patients in Q2, Q3, and Q4 had significantly higher ER stress [BiP] when compared with Q1 [p = 0.034, 0.040, and 0.034, respectively]. Conclusions: We developed and validated an ex vivo intestinal epithelial cell culture system and showed that patients with more ER stress and autophagy risk alleles have augmented epithelial ER stress responses. We thus presented a personalised approach whereby patient-specific defects can be identified, which in turn could help in selecting tailored therapies.
Introduction
Inflammatory bowel diseases [IBD] comprise a spectrum of intestinal inflammatory conditions with Crohn's disease [CD] and ulcerative colitis [UC] as the two main entities. They are characterised by chronic inflammation of the gastrointestinal tract and are believed to result from a dysregulated immune response towards the intestinal microbiota in genetically predisposed individuals. 1 Physicians and patients still face multiple challenges, as no curative treatment yet exists. A significant advance in management of IBD was the introduction of biologic agents targeting tumour necrosis factor [TNF] . 2 Almost two decades following their approval, a second and third class of biologic agents, respectively targeting gut-homing α 4 β 7 integrin-positive T-lymphocytes and interleukins [IL]-12/23, have been added to the therapeutic options. All approved biologic agents suppress a general adaptive immune response instead of the desired targeting of underlying pathogenic triggers. [3] [4] [5] Second, steroid-free clinical remission and mucosal healing, two important treatment goals, are observed in no more than 30-35% of patients, with large inter-patient variability in treatment response. The search for predictive biomarkers has been unsuccessful so far and, as a consequence, prediction of therapeutic success is poor. 6 Genetic association and gene/protein expression studies have uncovered novel underlying pathophysiological pathways that are currently under [pre] clinical evaluation as a therapeutic target. IL-12/23 and Smad7/TGF-B signalling, endoplasmic reticulum [ER] stress, and autophagy are accepted key players in IBD pathogenesis and are targeted by specific small molecules or antibodies that are in different stages of therapeutic development. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] It is anticipated that treatment success will vary depending on which pathways drive disease in a given patient. Therefore, it will become increasingly important to identify triggers of disease in order to select the most appropriate therapy. 3, 6, 19 The intestinal epithelium is crucial for intestinal homeostasis and prevention of inflammation, as this tightly connected single cell layer limits translocation of luminal microorganisms and other antigens into the lamina propria. Intestinal epithelial cells [IECs] form a physical barrier that is maintained by strong, tight junction protein expression and a continuous epithelial cell proliferation in the stem cell compartment at the crypt base. [20] [21] [22] The role of the epithelial barrier in IBD is underscored by studies that associate barrier defects with disease progression and relapse. [23] [24] [25] As described above, several epithelial cell integrity pathways, such as ER stress and autophagy, have been associated with IBD. 21, 22, [26] [27] [28] ER stress signalling/unfolded protein response and autophagy are two well-characterised homeostatic pathways that closely collaborate and play a key role in the innate and adaptive immune system. [29] [30] [31] [32] Autophagy serves as an intracellular clearance mechanism for components of endogenous and exogenous origin, such as mitochondria, misfolded proteins, signalling complexes, and [pathogenic] microorganisms. 30 The unfolded protein response is triggered by an increased abundance of un-or misfolded proteins in the ER, also called ER stress. Prolonged or uncontrolled ER stress will eventually lead to inflammation and/or cell death. 29 Both pathways have been genetically associated with IBD, for example the ER stress-related XBP1 and ORMDL3 genes and the autophagy-related ATG16L1, IRGM, LRRK2, and ULK1 genes. [26] [27] [28] Nevertheless, little is known how these genetic variants functionally translate in patients with IBD. We hypothesise that inter-patient differences in the risk allele burden in these pathways will lead to distinctive functional readouts in IBD patient-derived epithelial cells.
Therefore, the aim of this study was to translate an individual's genetic risk in ER stress and autophagy into quantifiable, functional ER stress readouts, starting from patient-derived epithelial cells. To do so, we developed an ex vivo two-dimensional epithelial cell culture system starting from human endoscopically-derived biopsies, to quantify perturbed pathways in patients with IBD. As a proof of concept, we studied epithelial ER stress levels stratified by the number of ER stress and autophagy risk alleles.
Materials and Methods

Patients and ethical statement
Patients with IBD followed at the IBD unit of the University Hospitals Leuven, who were genotyped as part of the international Immunochip project, were selected based on their mutations in ER stress or autophagy genes [ Table 1 ; Supplementary Figure 1 , available as Supplementary data at ECCO-JCC online]. 26, 33 We selected patients with 0, 1, 2, or 3 ER stress risk alleles and patients who had ≤ 3, 4, 5, or ≥ 6 autophagy risk alleles, which was based on the risk allele distribution in the immunochipped IBD patient population at the University Hospitals Leuven [ Supplementary Figure 1] . Only single nucleotide polymorphisms [SNPs] with a call rate > 90% and a minor allele frequency > 0.01 were included. Mucosal biopsies [eight per patient] were obtained from the macroscopically non-inflamed colon of 35 patients undergoing endoscopy as part of their IBD management. Patient characteristics are provided in Table 2 . 
Isolation and culturing of IECs
The crypt isolation protocol and cell culture medium were adapted from the colonic organoid culture procedure which was developed by Sato et al.in 2011 . 34 Biopsies were immediately placed in DMEM-F12 [Lonza, Basel, Switzerland] containing glutamine [15 mM ], hepes [15 mM] , and penicillin/streptomycin [100 U/ml, Lonza, Basel, Switzerland] at 4°C for transport [on ice] to the research laboratory, and were stored [at 4°C] for up to 2 h until epithelial isolation was performed. First, the biopsies were washed in DMEM-F12, after which they were allowed to settle and the supernatant was discarded. Next, they were thoroughly washed with complete chelating solution [CCS, 0.996 g/l Na 2 HPO 4 *2H 2 O, 1.08 g/l KH 2 PO 4 , 5.6 g/l NaCl, 0.12 g/l KCl, 15 g/l saccharose, 10 g/l D-sorbitol, 80 mg/l DTT] by repeated pipetting. Finally, EDTA [10 mM, Thermo Scientific, Waltham, MA, USA] was added and the biopsy suspension was placed on a rocking platform at 4 °C for 45 min, after which the EDTA-containing solution was removed. The biopsy fragments were passed multiple times through a 10-ml pipette in CCS to mechanically disrupt the IECs from the remaining mucosal tissue, leaving them in suspension as the remaining fragments settled down. The supernatant was centrifuged, after which the cell pellet was washed one more time in DMEM-F12 before resuspending the IECs in expansion medium [for composition see Supplementary Antigen retrieval was performed in sodium citrate buffer at 120°C for 10', after which the cells were allowed to slowly cool to room temperature and were washed with PBS. Blocking was performed for 10' with Protein Block Serum-Free [Agilent, Santa Clara, CA, USA] for 10', after which they were incubated overnight at 4°C with the primary antibodies: mouse-anti-ZO-1 [ 
Quantitative real-time polymerase chain reaction [qRT-PCR] analysis
ER stress induction
IEC cultures were treated for 14 h [from the end of Day 5 until the beginning of Day 6] with the ER stress-inducing compound thapsigargin [0.4 µM, Sigma-Aldrich, Saint Louis, MO, USA] in order to enhance potential inter-patient differences, lysis and total protein measurement.
After 14 h of thapsigargin-treatment, the IECs were placed on ice, the medium was aspirated and the cells were rinsed with icecold PBS. Next, the IECs were scraped in PBS and spun down, the resulting cell pellet was resuspended in RIPA lysis buffer [Enzo Life Sciences, Farmingdale, New York, NY, USA] and lysis was performed by incubating the suspension for 45' on ice, followed by sonication. The cell lysate was spun down at maximal speed to pellet membrane fragments and the supernatant was used to determine the total protein content with the Pierce® BCA Protein Assay Kit [Thermo Scientific, Waltham, MA, USA], and the remainder was stored at -80 °C until enough samples were acquired to perform an ELISA. 
Results
IECs and epithelial characterisation
After isolation, the intestinal crypts retained their three-dimensional morphology while being suspended in the medium [ Figure 1A ]. During overnight incubation, the crypts sank and attached to the collagen-coated surface to form an epithelial monolayer. These two-dimensional IEC islands consisted of cuboidal cells, giving them a pavement-like appearance. Visually each IEC island was formed around a growth centre [ Figure 1B Cells remained viable in culture for approximately 12 days, after which local cell detachment and cell death occurred [ Figure 1C , red arrows]. The combined isolation and culture success rate was 81% [39 out of 48 isolations]. Failure was mostly due to low donor-dependent IEC isolation yields or inefficient cell attachment, but was independent of presence of ER stress or autophagy risk alleles.
In order to confirm the epithelial character, 4-day-old IEC cultures were stained for E-cadherin. 35, 36 Figure 3A and B illustrates how this epithelial transmembrane adherent junction protein was strongly expressed along the cell membranes of the cultured IECs. In order to rule out fibroblast contamination, we also performed a PDGFR-α staining which was negative in 4-day-old IEC cultures. A positive control staining for this latter antibody on IMR-90 fibroblast cells is provided in Supplementary Figure 3 The epithelial character of these ex vivo cell cultures was further assessed by measuring mRNA levels of CK-18 and CK-20 over time, as indicated in Figure 4 . Figure 4A and B illustrates how CK-20 is initially expressed at high levels and gradually decreases over time. Still, also at Day 7 (168 h post isolation [hpi]), expression levels were strongly present when compared with proliferating cultures of FHCs. Additionally, we also measured the expression of the intestinal epithelial stem cell marker LGR5 in IEC cultures at the same time points [24, 72, 120, 168 hpi] and showed that Lgr5 expression increased over time [ Figure 5 ].
Finally, we assessed the polarity along the apical-basolateral axis, by staining the cells for zonula occludens-1 [ZO-1]. We could show that ZO-1-postive signal [green] is distributed apically at a depth of 0-1500 nm, whereas this positive signal disappears completely when moving closer towards the basolateral side [ Figure 6s and 7].
Genetic risk in ER stress and autophagy genes and the epithelial ER stress response
The IEC cultures were microscopically monitored daily between the times of isolation and lysis in order to exclude wells that had an aberrant morphology or showed signs of cell death. In order to determine the cells' intrinsic capability to cope with ER stress, we measured BiP levels with and without a 14-h treatment with the ER stressor thapsigargin, from Day 5 until Day 6.
Patients 
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100 µm 20 µm Figure 1A ], we were unable to include these patients as we thus had only four patients with four ER stress risk alleles in our entire genotyped patient cohort. These specific patients did not undergo an endoscopic investigation at our clinic during the time of inclusion. IECs from patients with three risk alleles had significantly more ER stress induction rates when compared with patients with one or with two risk alleles [ Figure 8A , p = 0.0262 and 0.0430, respectively]. We also grouped patients in risk quartiles, based on the number of risk alleles [RA] Figure 8B ]. No significant differences were observed between these groups [ Figure 3B ], although a trend towards higher ER stress induction rates in Q3 and Q4 compared with Q1 [p = 0.0507 and 0.1535, respectively] was seen.
Finally, given that autophagy and ER stress show a clear interplay, 31, 32, 37, 38 ER stress and autophagy risk alleles were combined. This combination of risk alleles led to a change in the definition of the genetic risk quartiles [Q1: ≤ 4 RA, Q2: 5 RA, Q3: 6 RA, Q4: ≥ 7 RA; Supplementary Figure 1C] Figure 8C ]. Patients in Q2, Q3, and Q4 had significantly higher ER stress induction rates when compared with Q1 [p = 0.0343, 0.0401, and 0.0343, respectively].
At baseline, there were no significant differences in BiP mRNA or protein expression between the different patient subgroups [ Figures  9 and 10 , respectively].
Discussion
In this study, we developed a novel ex vivo two-dimensional IEC culture model, allowing characterisation and quantification of pathogenic pathways in IBD in a patient-specific manner. We demonstrated that these biopsy-derived epithelial cell cultures remain viable for about 12 days, and isolation success was more than 80%. The epithelial character was illustrated by a clear E-cadherin staining along the membranes of IECs, which resembles immunohistochemical E-cadherin stainings on human colonic tissue sections. 39, 40 We could not detect the fibroblast marker PDGFR-α, which indicates that these cultures were free of contamination by mesenchymal cells. The areas where the crypts originally attached remained a centre of IEC proliferation, as indicated by the abundance of KI67-positive cells. Daughter cells get pushed outward, and either differentiate into intestinal epithelial cell types or retain their proliferative phenotype. We also analysed gene expression levels of two epithelial cytokeratins over time. Cytokeratin 18 is a type-1 keratin that is found in all simple epithelial tissues such as the intestinal epithelial lining and the proximal tubule of the kidney. 41, 42 We could detect stable CK-18 mRNA levels, illustrating that our monolayer cultures have an epithelial character that is not lost over time. Cytokeratin 20, on the other hand, also belongs to the type-1 keratin family and is predominantly expressed in differentiated IEC subtypes. [41] [42] [43] In our IEC cultures, CK-20 mRNA levels were decreasing, suggesting loss of differentiation over time. This is further supported by the inverse correlation between the time-dependent CK-20 and LGR5 mRNA expression:
LGR5 expression increases over time, indicating a rise in the relative abundance of epithelial stem cells.
Finally, since polarity is an important aspect of a functional epithelial monolayer, we stained the cells for zonula occludens-1 [ZO-1], a tight junction protein which should be located at the apical side of the epithelium. We could indeed show that ZO-1 is distributed apically when compared with the nuclei.
Taken together, these data confirm that the isolated cells form polarised epithelial monolayers that contain both proliferating and differentiated cells. This model therefore shows the potential for measuring specific biological responses in individual patients stratified on genetic susceptibility, disease location and/or therapies.
As a further proof of concept, we also showed for the first time that the genetic susceptibility in two important pathways associated with IBD, namely ER stress and autophagy, can be functionally translated and quantified in individual patients using biopsy-derived IECs. We chose to focus on these two pathways because of their functional interaction and importance for IEC homeostasis. [29] [30] [31] We measured intracellular BiP-levels as a quantitative readout for the amount of ER stress. BiP, or GRP78/HSPA5, is a molecular chaperone protein that is strongly involved in ER stress signalling. It is upregulated when ER stress increases [eg after thapsigargin treatment] and controls further activation of all three branches of the unfolded protein response [the ER stress signalling pathway]. 44, 45 Two ER stress-related risk loci have been identified so far [rs35873774 and rs2872507], and patients carrying more than two risk alleles in this pathway were rare in our patient population. Therefore, it was impossible to further group patients into genetic risk quartiles. Hence, the highest risk group [carrying 3 RA] contained only three patients. Nevertheless, this patient group showed a significant increase in thapsigargin-mediated ER stress [BiP] induction when compared with patients carrying two or one risk allele [s] . These data illustrate a functional, quantifiable consequence of two confirmed genetic risk variants in the ER stress pathway in patients with IBD.
By clearing un-or misfolded intracellular proteins, autophagy by itself is an essential component of ER stress signalling. 31, 37 Accumulating evidence underscores the interaction of autophagy and ER stress signalling in the intestinal epithelium. 31, 32, 38, 46 For example, Adolph et al. showed in mice that epithelial-specific genomic deletion of autophagy genes leads to increased ER stress signalling, and vice versa. Both mechanisms thus seem to play compensatory roles in maintaining IEC homeostasis and preventing inflammation, which is further demonstrated by the spontaneous ileitis that only occurs when both pathways are genetically perturbed. 46 Since it has been clearly demonstrated that dysfunctional autophagy also leads to increased ER stress in IECs, 32, 38, 46, 47 we tried to confirm these murine findings using our human IEC model, but were unable to detect significant differences in ER stress induction rates between patients belonging to different autophagy genetic risk quartiles. However, when ER stress and autophagy risk alleles were combined, a significant association between genetic risk and ER stress induction rates was seen. This indicates that the genetic risk in both pathways should be taken into account when looking at the functional level. Finally, we could show that none of these patient subgroups showed significant baseline differences in the expression of BiP, at either the mRNA or the protein level. Therefore, these results suggest that it is mainly the ability to cope with ER stress-inducing insult [eg thapsigargin] that is affected, rather than the baseline ER stress levels in stress-free conditions. Our findings do not only show the functionality of this new ex vivo IEC culture system, they also demonstrate that disease-associated molecular pathways can be quantified in an individual patient. This may provide therapeutic opportunities, such as the administration of ER stress-reducing molecules in patients demonstrating increased ER stress levels in IECs. Despite the fact that ER stress is regarded a key player in the pathogenesis of IBD, it is currently not being considered as a possible therapeutic strategy. Yet, the ER stress-reducing conjugated bile acid tauroursodeoxycholic acid [TUDCA] may reduce epithelial apoptosis and inflammation, and was shown to reduce severity of colitis in multiple IBD mouse models. [15] [16] [17] [18] Furthermore, oral administration of TUDCA in the context of other diseases has not been associated with any adverse events so far. [48] [49] [50] [51] It would therefore be very interesting to study if TUDCA could reduce inflammation in patients with IBD characterised by increased ER stress levels, as demonstrated in our human culture model. Besides TUDCA, other ER stress-reducing compounds, such as 4-phenylbutyrate [PBA] and glutamine, could also be considered as these compounds also have shown some effectiveness in murine IBD models. [13] [14] [15] Likewise, the autophagic inducer rapamycin was effective in IBD case reports but failed to show efficacy in a randomised placebocontrolled trial. [9] [10] [11] [12] We wonder if functional characterisation of the patients randomised in this study for defects in autophagy would shed a different light on the results.
Since these cells are grown in two dimensions, the apical side is easily accessible for pharmaceutical compounds or micro-organisms, which is a great advantage compared with the three-dimensional intestinal organoid model originally described by Sato et al. 34 Intestinal organoids are an excellent model to investigate multiple key aspects of intestinal epithelial physiology and pathologies such as epithelial stem cell proliferation studies. However, our ex vivo monolayer protocol may offer several practical advantages and an easier to use system for exposure studies.
This ex vivo IEC culture system may be used or modified for other applications than the investigation of IBD-associated genetic defects at the site of the intestinal epithelium. Epithelial defects in other diseases, like coeliac disease, post-infectious irritable bowel syndrome, and intestinal cancer, could be further elucidated and lead to more personalised therapeutic approaches. Another potential application of the ex vivo cell culture system is personalised drug toxicity-screening assays. We are currently further modifying our protocol allowing the IECs to grow on transwell membranes in order to perform permeability assays. This setup could also be used for co-culturing IECs with other relevant intestinal cell types such as macrophages.
In summary, we have developed and characterised a twodimensional IEC culture system that allows easy exploration of patient-specific epithelial defects and/or responses. We could detect defects in epithelial ER stress-handling in genetically predisposed patients, and hereby show that this approach can be used for the detection and quantification of underlying pathogenic mechanisms. Personalised tools such as this will become highly valuable in complex disorders and will allow treatment of a defective pathway instead of a disease phenotype. 
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